Sign In
Buy CNMD
$35.16
+0.0300 (+0.0854%)
At Close: Jun 05, 2026
CONMED Corporation to Present at the BofA Securities Virtual Healthcare Conference
08:05pm, Monday, 04'th May 2020
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at t
CONMED (CNMD) Q1 Earnings and Revenues Surpass Estimates
02:56pm, Monday, 04'th May 2020
CONMED's (CNMD) first-quarter results gain from strong performance in General Surgery segment and expansion in margins.
CONMED Corporation to Present at the BofA Securities Virtual Healthcare Conference
12:00am, Monday, 04'th May 2020
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice Presid
Edited Transcript of CNMD earnings conference call or presentation 29-Apr-20 8:30pm GMT
08:18pm, Friday, 01'st May 2020
Q1 2020 Conmed Corp Earnings Call
Edited Transcript of CNMD earnings conference call or presentation 29-Apr-20 8:30pm GMT
02:27pm, Friday, 01'st May 2020
Q1 2020 Conmed Corp Earnings Call
New York, April 30, 2020 -- Reportlinker.com announces the release of the report "Global Soft Tissue Allograft Market - Premium Insight, Competitive News Feed Analysis, Company.
Stifel Maintains Buy on Conmed, Raises Price Target to $82
12:51pm, Thursday, 30'th Apr 2020CONMED's (CNMD) "Hold" Rating Reiterated at Needham & Company LLC
11:00am, Thursday, 30'th Apr 2020
CONMED (NASDAQ:CNMD)‘s stock had its “hold” rating reaffirmed by stock analysts at Needham & Company LLC in a report issued on Thursday, AnalystRatings.com reports. CNMD has been the topic of se
Columbus Circle Investors Cuts Stock Position in CONMED Co. (NASDAQ:CNMD)
10:12am, Thursday, 30'th Apr 2020
Columbus Circle Investors lowered its stake in CONMED Co. (NASDAQ:CNMD) by 47.9% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1
Needham Maintains a Hold Rating on Conmed (CNMD)
09:31am, Thursday, 30'th Apr 2020
Needham analyst Michael Matson maintained a Hold rating on Conmed (CNMD) today. The company's shares closed last Wednesday at $74.40. According to
Needham Maintains a Hold Rating on Conmed (CNMD)
09:31am, Thursday, 30'th Apr 2020
Needham analyst
Michael Matson
maintained a
Hold
rating on Conmed (
CNMD
–
Research Report
) today. The company’s shares closed last Wednesday at $74.40.
According to
TipRanks.com
, Matson is a 5-
CONMED Corporation (CNMD) CEO Curt Hartman on Q1 2020 Results - Earnings Call Transcript
11:47pm, Wednesday, 29'th Apr 2020
CONMED Corporation (NYSE:CNMD) Q1 2020 Earnings Conference Call April 29, 2020 4:30 p.m. ET Company Participants Curt Hartman - President and CEO Todd Garner -
Conmed (CNMD) Q1 Earnings and Revenues Top Estimates
09:35pm, Wednesday, 29'th Apr 2020
Conmed (CNMD) delivered earnings and revenue surprises of 15.91% and 2.60%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Conmed (CNMD) Q1 Earnings and Revenues Top Estimates
09:35pm, Wednesday, 29'th Apr 2020
Conmed (CNMD) delivered earnings and revenue surprises of 15.91% and 2.60%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Conmed: 1Q Earnings Snapshot
08:29pm, Wednesday, 29'th Apr 2020
UTICA, N.Y. (AP) _ Conmed Corp. (CNMD) on Wednesday reported first-quarter earnings of $5.9 million. The Utica, New York-based company said it had net income of 20 cents per share. Earnings, adjusted
